Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U4atac small nuclear 3, pseudogene (RNU4ATAC3P) is a non-functional genomic sequence classified as a pseudogene. It shares homology with the RNU4ATAC gene, which encodes the U4atac small nuclear RNA, an essential component of the minor spliceosome. Unlike its parent gene, RNU4ATAC3P does not produce a functional RNA product and is not involved in normal or disease pathogenesis. Pseudogenes such as RNU4ATAC3P typically arise from duplication or retrotransposition events and may occasionally play regulatory roles at the RNA level, but no such function has been described for this locus[1][5]. The RNU4ATAC3P gene is annotated as a *pseudogene* in major databases, indicating it does not encode a functional RNA[1]. The functional RNU4ATAC gene, not the pseudogene, is critical for minor intron splicing and is associated with developmental disorders when mutated[6][7]. Pseudogenes in general might affect gene expression (e.g., via competing endogenous RNA or small interfering RNAs) in some cases[5], but there is no evidence that RNU4ATAC3P has such a functional role. No drugs, disease biomarkers, or safety concerns are associated with this sequence[1][5]. It is not considered a receptor, enzyme, transporter, transcription factor, or therapeutic target by any biomedical resource. If you need information about the functional gene **RNU4ATAC** instead, it is distinct and has known disease associations and biological functions relevant to splicing disorders[2][4][6][7].
None known (No approved or experimental drugs are known to target this pseudogene.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4atac small nuclear 3, pseudogene (RNU4ATAC3P).